Evidence map›Paper›PMID 28686990›Full record

ArticleDrug and alcohol dependence2017

Left frontal pole theta burst stimulation decreases orbitofrontal and insula activity in cocaine users and alcohol users.

Colleen A Hanlon, Logan T Dowdle, Brittany Correia, Oliver Mithoefer, Tonisha Kearney-Ramos, Daniel Lench, Millie Griffin, Raymond F Anton, Mark S George

2 registry-linked trialsAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 72 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06372288 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Theta Burst Transcranial Magnetic Stimulation for the Treatment of Methamphetamine Use Disorder

TypeinterventionalSponsorCarilion ClinicRan2023 to 2025Enrolled40ConditionsMethamphetamine AbuseArmsTranscranial Magnetic Stimulation, Sham Transcranial Magnetic Stimulation
NCT07230990 narecruitingnot on this mapstarted 2026, after this paper: background citation

Mechanisms Of Orbitofrontal Stimulation in Depression (MOOD)

TypeinterventionalSponsorSubha SubramanianRan2026 to 2030Enrolled80ConditionsMajor Depressive Disorder (MDD)ArmsSham TMS, Active TMS
3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. A systematic review and meta-analysis of neuromodulation therapies for substance use disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Pooled it
  3. Pooled it
  4. Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2021
    Guideline
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Translating macaque frontopolar cortex discoveries into psychiatric treatments.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  16. Article
  17. Addiction biology · 2026
    Article
  18. Article
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Colleen A HanlonDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, United States; Department of Neurosciences, Medical University of South Carolina, United States; Center for Biomedical Imaging, Medical University of South Carolina, United States. Electronic address: hanlon@musc.edu.
Logan T DowdleDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, United States; Department of Neurosciences, Medical University of South Carolina, United States.
Brittany CorreiaDepartment of Biology, Vanderbilt University, United States.
Oliver MithoeferDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, United States.
Tonisha Kearney-RamosDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, United States; Department of Neurosciences, Medical University of South Carolina, United States.
Daniel LenchDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, United States; Department of Neurosciences, Medical University of South Carolina, United States.
Millie GriffinDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, United States; Department of Neurosciences, Medical University of South Carolina, United States.
Raymond F AntonDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, United States; Department of Neurosciences, Medical University of South Carolina, United States; Center for Biomedical Imaging, Medical University of South Carolina, United States.
Mark S GeorgeDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, United States; Department of Neurosciences, Medical University of South Carolina, United States; Center for Biomedical Imaging, Medical University of South Carolina, United States; Ralph H Johnson Veterans Affairs Medical Center, United States.

Funding

TREATING ETHANOL WITHDRAWAL WITH LORAZEPAM/NALTREXONEP50AA010761 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HOWARD C. BECKER · 1996 to 2026
$46.8M
Selective Restoration of KCNQ Channel Inhibition in the PFC to Inhibit Cue-InducP50DA015369 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KALIVAS, PETER W · 2003 to 2017
$18.6M
DRUG ABUSE TRAINING PROGRAMT32DA007288 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Christopher W Cowan, Rachel Penrod-Martin · 1991 to 2026
$11.8M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
NEUROSCIENCE OF DRUG ABUSE TRAINING PROGRAMT32DA007246 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CHILDERS, STEVEN R · 1991 to 2011
$2.2M
Career Development and Mentoring in Clinical/Translational Alcohol ResearchK05AA017435 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ANTON, RAYMOND F · 2008 to 2017
$2.2M
Longitudinal study of functional connectivity among cocaine users in treatmentR01DA036617 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HANLON, COLLEEN A · 2014 to 2018
$1.6M
Impact of vMPFC Brain Stimulation on Outcomes in Treatment-Engaged Cocaine UsersR21DA041610 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HANLON, COLLEEN A · 2016 to 2017
$391k
Using Neuroimaging to Evaluate rTMS as a Treatment for Pain in Non-Medical Prescription Opioid UseF31DA043330 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DOWDLE, LOGAN · 2017 to 2019
$104k
NIAAA NIH HHS K05 AA017435NIAAA NIH HHS P50 AA010761NIDA NIH HHS F31 DA043330NIDA NIH HHS P50 DA015369NIDA NIH HHS R01 DA036617NIDA NIH HHS R21 DA041610NIDA NIH HHS T32 DA007246NIDA NIH HHS T32 DA007288
6 · The paper itself

Abstract

backgroundPreclinical research has demonstrated a causal relationship between medial prefrontal cortex activity and cocaine self-administration. As a step towards translating those data to a neural circuit-based intervention for patients, this study sought to determine if continuous theta burst stimulation (cTBS) to the left frontal pole (FP), would attenuate frontal-striatal activity in two substance-dependent populations.

methodsForty-nine substance dependent individuals (25 cocaine, 24 alcohol) completed a single-blind, sham-controlled, crossover study wherein they received 6 trains of real or sham cTBS (110% resting motor threshold, FP1) each visit. Baseline evoked BOLD signal was measured immediately before and after real and sham cTBS (interleaved TMS/BOLD imaging: single pulses to left FP; scalp-to-cortex distance covariate, FWE correction p<0.05)

resultsAmong cocaine users, real cTBS significantly decreased evoked BOLD signal in the caudate, accumbens, anterior cingulate, orbitofrontal (OFC) and parietal cortex relative to sham cTBS. Among alcohol users, real cTBS significantly decreased evoked BOLD signal in left OFC, insula, and lateral sensorimotor cortex. There was no significant difference between the groups.

conclusionsThese data suggest that 6 trains of left FP cTBS delivered in a single day decreases TMS-evoked BOLD signal in the OFC and several cortical nodes which regulate salience and are typically activated by drug cues. The reliability of this pattern across cocaine- and alcohol-dependent individuals suggests that cTBS may be an effective tool to dampen neural circuits typically engaged by salient drug cues. Multiday studies are required to determine it this has a sustainable effect on the brain or drug use behavior.

Indexed as

Frontal LobeCocaineCorpus StriatumCross-Over StudiesCuesGyrus CinguliHumansParietal LobePrefrontal CortexReproducibility of ResultsSensorimotor CortexSingle-Blind MethodTranscranial Magnetic StimulationCocaineFunctional MRIMesolimbicNeuromodulationOrbitofrontal

Identifiers

PMID28686990
PMCPMC5896018

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.